| Gene symbol | TGFB2 | Synonyms | G-TSF, LDS4, TGF-beta2 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q41 | dbXrefs | |
| Description | transforming growth factor beta 2 | ||||
| GTO ID | GTC0694 |
| Trial ID | 2021-001213-36 |
| Disease | Diabetic Macular Edema |
| Altered gene | TGFB2 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | ISTH0036 |
| Phase | Phase2 |
| Recruitment status | Ongoing |
| Title | TGF-BETa 2 antisense ISTH0036 for the Treatment of diabetic |
| Year | 2021 |
| Country | Austria |
| Company sponsor | Isarna Therapeutics GmbH |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||